PLoS ONE (Jan 2013)

Use of net reclassification improvement (NRI) method confirms the utility of combined genetic risk score to predict type 2 diabetes.

  • Claudia H T Tam,
  • Janice S K Ho,
  • Ying Wang,
  • Vincent K L Lam,
  • Heung Man Lee,
  • Guozhi Jiang,
  • Eric S H Lau,
  • Alice P S Kong,
  • Xiaodan Fan,
  • Jean L F Woo,
  • Stephen K W Tsui,
  • Maggie C Y Ng,
  • Wing Yee So,
  • Juliana C N Chan,
  • Ronald C W Ma

DOI
https://doi.org/10.1371/journal.pone.0083093
Journal volume & issue
Vol. 8, no. 12
p. e83093

Abstract

Read online

BackgroundRecent genome-wide association studies (GWAS) identified more than 70 novel loci for type 2 diabetes (T2D), some of which have been widely replicated in Asian populations. In this study, we investigated their individual and combined effects on T2D in a Chinese population.MethodologyWe selected 14 single nucleotide polymorphisms (SNPs) in T2D genes relating to beta-cell function validated in Asian populations and genotyped them in 5882 Chinese T2D patients and 2569 healthy controls. A combined genetic score (CGS) was calculated by summing up the number of risk alleles or weighted by the effect size for each SNP under an additive genetic model. We tested for associations by either logistic or linear regression analysis for T2D and quantitative traits, respectively. The contribution of the CGS for predicting T2D risk was evaluated by receiver operating characteristic (ROC) analysis and net reclassification improvement (NRI).ResultsWe observed consistent and significant associations of IGF2BP2, WFS1, CDKAL1, SLC30A8, CDKN2A/B, HHEX, TCF7L2 and KCNQ1 (8.5×10(-18)ConclusionIn a Chinese population, the use of a CGS of 8 SNPs modestly but significantly improved its discriminative ability to predict T2D above and beyond that attributed to clinical risk factors (sex, age and BMI).